<DOC>
	<DOCNO>NCT01451164</DOCNO>
	<brief_summary>To investigate efficacy safety OPC-34712 comparison placebo patient schizophrenia .</brief_summary>
	<brief_title>A Dose-finding Trial OPC-34712 Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients age 18 year old less 65 year ( time inform consent ) diagnose schizophrenia base DSMIVTR diagnostic criterion Patients hospitalize , judge require hospitalization , acute relapse schizophrenia time informed consent Patients experience acute exacerbation psychotic symptom Female patient breastfeed positive pregnancy test ( urine ) result prior receive investigational medicinal product Patients present first episode schizophrenia base clinical judgment investigator Patients diagnose disease schizophrenia ( schizoaffective disorder , major depressive disorder , bipolar disorder , posttraumatic stress disorder , anxiety disorder , delirium , dementia , amnesia , cognitive disorder ) base current DSMIVTR Axis Î™ criterion , diagnose personality disorder ( borderline , paranoid , histrionic , schizotypal , schizoid , antisocial )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>